维生素 D2，1a-羟基-

维生素 D2，1a-羟基-（CAS 54573-75-0）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

Doxercalciferol is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, as well as for the treatment of secondary hyperparathyroidism in patients with Stage 3 or Stage 4 chronic kidney disease.Avoid antacids. Specifically, avoid magnesium-containing antacids as co-administration with doxercalciferol increases the risk of hypermagnesemia.

同义词与商品名

Doxercalciferol; 54573-75-0; 1-Hydroxyergocalciferol; 1alpha-Hydroxyergocalciferol; Hectorol; 1alpha-hydroxyvitamin D2; 1-alpha-Hydroxyvitamin D2; 1-alpha-hydroxyergocalciferol; Doxercalciferolum; 3DIZ9LF5Y9; (1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol; TSA-840; GZ427397; CHEBI:4712; doxacalciferol; 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1alpha,3beta,5Z,7E,22E)-

GHS 危害分类

Reported hazard statements	H300 (100%)

H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

公开数据库对它的描述

Vitamin D2, 1a-Hydroxy- · CAS 54573-75-0 · C28H44O2. UNII 3DIZ9LF5Y9.

物理形态与操作说明

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。